Concepedia

Michael P. Rettig

MP

77

Publications

6.2K

Citations

35

H-Index

1994

Active since

Affiliations

Washington University in St. Louis(Current)

MacroGenics (United States)

The University of Texas MD Anderson Cancer Center

Emory University

Mallinckrodt (United States)

Michael P. Rettig is an author at Washington University in St. Louis specializing in medicine, hematology, and cell biology.

ORCID

Top concepts

Publications per year

1994–2024

77

Publications

77

Chemosensitization of acute myeloid leukemia (AML) following mobilization by the CXCR4 antagonist AMD3100

Bruno Nervi, Pablo Ramírez, Michael P. Rettig et al. · Blood · 2008 · 477 citations · Full text

Immune Escape of Relapsed AML Cells after Allogeneic Transplantation

Matthew Christopher, Allegra A. Petti, Michael P. Rettig et al. · New England Journal of Medicine · 2018 · 457 citations · Full text

A phase 1/2 study of chemosensitization with the CXCR4 antagonist plerixafor in relapsed or refractory acute myeloid leukemia

Geoffrey L. Uy, Michael P. Rettig, Ibraheem Motabi et al. · Blood · 2012 · 381 citations · Full text

An “off-the-shelf” fratricide-resistant CAR-T for the treatment of T cell hematologic malignancies

Matthew Cooper, Jaebok Choi, Karl Staser et al. · Leukemia · 2018 · 381 citations · Full text

, , +5

Impact of Mobilization and Remobilization Strategies on Achieving Sufficient Stem Cell Yields for Autologous Transplantation

Iskra Pusic, Shi Yuan Jiang, Scott Landua et al. · Biology of Blood and Marrow Transplantation · 2008 · 348 citations · Full text

Rows per page

1–5 of 77